Appraisal and reflections on the recently published ConSEPT and EcLiPSE trials – what do they mean for the treatment of paediatric status epilepticus?
JC: Enter Sandman – Which Agent as Second Line in Paediatric Status Epilepticus? Read More
Natalie May’s notes accompanying her 2015 smaccMINI talk explore assessment of the previously well child with altered consciousness. The post covers protecting the brain and organising possible causes through the ‘5MF’ framework, including infection, metabolic illness, medication effects and seizures.
You Snooze, You Lose? #smaccUS The Child with Altered Consciousness Read More
This 2015 journal club examines a trial comparing intravenous lorazepam and diazepam for children with convulsive status epilepticus. Alongside seizure control and adverse effects, the appraisal explores blinding, per-protocol analysis and why failing to demonstrate superiority does not prove that the treatments are equivalent.
JC: One Benzo Fits All? Lorazepam vs Diazepam for Paediatric Status Epilepticus Read More
When a child’s low blood glucose improves, what still needs explaining? In this 2012 discussion, Natalie May explores hypoglycaemia beyond diabetes, the possibility of underlying illness, and the decisions around investigation, observation and referral to paediatric colleagues.
Oh, Sugar! Paediatric Hypoglycaemia Read More
